BrightSeed applies artificial intelligence and machine learning to map bioactive compounds in plants and predict their health benefits for humans. The company's platform, called Forager, analyzes plant molecular structures to identify compounds that could be developed into targeted nutrition products, supplements, and therapeutics. BrightSeed partners with food and nutrition companies to develop science-backed products that address specific health conditions and optimize human health through plant-based compounds.
BrightSeed has received investment from 1 venture capital firm.
Biotechnology company using AI to discover bioactive compounds in plants for developing targeted nutrition and health products.
BrightSeed has received investment from AgFunder. These venture capital firms and investors provide both capital and strategic support.
BrightSeed has raised $68M in total funding, with their most recent round being a Series A. The company operates in the Biotech sector.
BrightSeed was founded in 2017 and is headquartered in San Francisco, California.
BrightSeed operates in the Biotech sector. Biotechnology company using AI to discover bioactive compounds in plants for developing targeted nutrition and health products.
